Memory Losses Completed Phase 1 / 2 Trials for Risedronic acid (DB00884)

Also known as: Memory Loss / Loss of memory / Amnesia / Amnesia NOS / Memory loss of

IndicationStatusPhase
DBCOND0031656 (Memory Losses)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01268046Aging and Estrogen on Cortical FunctionOther